EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 31 March 2022

News

Pharmaceutical industry response to the war in Ukraine
05 October 2022

Supporting people affected by the war Read more

Blogs

2022 – A key year to put the fight against cancer at the top of the EU political agenda? (1)...
31 March 2022 - Clarisse Lhoste

Learning from the past, do better in the future addressing the whole cancer pathway Read more

Videos

How can AI help accelerate drug discovery?
An interview with Regina Barzilay, Distinguished Professor of AI and Health at MIT Jameel Clinic and the School of Engineering... Read more

Innovate or stagnate
As a region we can chose to innovate or stagnate, and if innovation happens elsewhere then high value, highly skilled... Read more

Regulatory Road to Innovation

As the EU reviews its Pharmaceutical Strategy, we must seize the once in a generation opportunity to create an attractive innovation ecosystem for the next generation of medicines, diagnostics and vaccines. Discover our #RegulatoryRoadToInnovation

We published

EFPIA’s Regulatory Road to Innovation Could Help Restore Europe as World Leader
On 19 March 2022 (The Lancet, in kiosks)

As Europe re-evaluates its pharmaceutical policy framework, the challenge for the next decade is not if medical innovation... Read more

EFPIA’s Regulatory Road To Innovation – Back To The Cutting Edge
On 29 March 2022 (Pink Sheet)

Ahead of the first reviewal of European pharma legislation in almost 20 years, senior executives at Lilly and MSD assess... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu